Could a migraine pill help heal spinal cord injuries?
NCT ID NCT06677229
First seen Oct 01, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tests a drug called TZ-161 (Eletriptan hydrobromide), originally used for migraines, in people with recent spinal cord injury. The goal is to see if it is safe and can help improve recovery. About 28 adults aged 18-65 with a thoracic spinal injury will receive the drug within 24 hours of their injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.